Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

48.02USD
29 Jul 2016
Change (% chg)

$-0.20 (-0.41%)
Prev Close
$48.22
Open
$48.18
Day's High
$48.34
Day's Low
$47.83
Volume
2,739,694
Avg. Vol
1,574,198
52-wk High
$48.50
52-wk Low
$32.18

BAX.N

Chart for BAX.N

About

Baxter International Inc., through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $26,519.66
Shares Outstanding(Mil.): 552.26
Dividend: 0.13
Yield (%): 1.08

Financials

  BAX.N Industry Sector
P/E (TTM): 5.54 42.33 39.69
EPS (TTM): 8.66 -- --
ROI: -- 11.52 14.44
ROE: -- 13.49 15.49

BRIEF-Baxter presents results of study related to REVACLEAR dialyzer

* Baxter presents new evidence demonstrating REVACLEAR Dialyzer associated with lower drug use during hemodialysis

Jul 27 2016

BRIEF-Baxter Q2 earnings $2.19/shr from cont ops

July 26 Baxter Reports Second Quarter 2016 Results And Raises Financial Outlook For Full

Jul 26 2016

BRIEF-Baxter International sets quarterly dividend of $0.13 per share

* Sets quarterly dividend of $0.13 per share Source text for Eikon: Further company coverage:

Jul 19 2016

BRIEF-Co Don says Bauerfeind AG is new major shareholder

* Bauerfeind AG indirectly holds a blocking minority of 25 pct of the shares in Co.Don AG Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 12 2016

BRIEF-Baxter International announces health canada approval of AMIA automated peritoneal dialysis system

* Baxter international says announces health canada approval of AMIA automated peritoneal dialysis system with sharesource connectivity platform

Jun 29 2016

BRIEF-Baxter International reports data results from infusion system

* Data shows sigma spectrum infusion system users achieved 97 percent drug library compliance rate within the first month of implementation1 Source text for Eikon: Further company coverage:

Jun 16 2016

Theranos sued over blood tests, in proposed class action

Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers.

May 26 2016

Theranos sued over blood tests, in proposed class action

Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers.

May 26 2016

UPDATE 1-Theranos sued over blood tests, in proposed class action

May 26 Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers.

May 26 2016

Theranos sued over blood tests, in proposed class action

May 26 Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers.

May 26 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.